Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

<em id="g8rfj"><pre id="g8rfj"></pre></em>

<pre id="g8rfj"><td id="g8rfj"></td></pre>

<button id="g8rfj"></button>

<pre id="g8rfj"><menuitem id="g8rfj"></menuitem></pre>

<abbr id="g8rfj"></abbr>

You are here: Industry Insights > Napabucasin Study

News List

Boston Biomedical Discontinues Napabucasin Study americanpharmaceuticalreview
July 04, 2019
Boston Biomedical has announced the CanStem111P study evaluating the safety and efficacy of investigational agent napabucasin plus weekly nab-paclitaxel with gemcitabine versus weekly nab-paclitaxel with ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 滬ICP備05034851號(hào)-182 滬公網(wǎng)安備31010402010101號(hào)
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight July 2025

PharmaSources Customer Service

<u id="rfem9"><optgroup id="rfem9"></optgroup></u>

<ul id="rfem9"></ul>

<sub id="rfem9"></sub>

<sub id="rfem9"><p id="rfem9"></p></sub>

<meter id="rfem9"></meter>

<ruby id="rfem9"></ruby>

<blockquote id="rfem9"><samp id="rfem9"></samp></blockquote>

<kbd id="rfem9"><font id="rfem9"></font></kbd>